...YORK (Fortune) -- At first glance, Pfizer seems more virile than ever. The pharmaceutical giant has a sector-leading $26 billion in cash, and its profits last quarter were triple the year before. Pfizer's portfolio includes household names such as...
...sensitive equities with the strongest balance sheets. A high, well covered dividend yield is a plus. Major drug companies like Pfizer, Inc. (NYSE: PFE) and Bristol-Myers Squibb Co. (NYSE: BMY) fit that description. Consumer Staples firms like The...
...sold by Pfizer as Norvasc; and an alpha blocker, doxazosin, which Pfizer sold as Cardura. Cardura was added only after Pfizer, which had already agreed to contribute $20 million to the trial’s costs, increased that to $40 million, Dr. Cutler said....
...Approval to Sell Coated Nicotine Gum II-22 Pfizer Receives Chinese Approval for Clinical Trials on Smoking Cessation Aid II-22 Pfizer Receives EC Approval for New Varenicline II-22 Formation of Sanofi-Aventis II-22 AXIA Health Management Acquires Smoking...
Background
Pfizer Incorporated (NYSE: PFE) is a major pharmaceutical company, which ranks number one in the world in sales. The company is based in New York City. It produces the number-one selling drug Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), the long-acting antibiotic Zithromax (azithromycin), the well-known erectile dysfunction drug Viagra (sildenafil citrate), and the anti inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside USA and Canada, mainly in South America).
You must have Javascript and Flash version 8+ enabled to see this content.
Timeline
You must have Javascript and Flash version 8+ enabled to see this content.
